RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damag-Reference-Cited by-同舟云学术

RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damag

Published:2011-08 Issue:8 Volume:63 Page:1142-1149
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Pincus Theodore,Furer Victoria,Keystone Edward,Yazici Yusuf,Bergman Martin J.,Luijtens Kristel

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.20481/fullpdf

Reference22 articles.

1. Interpretation and power of pooled index;Goldsmith;J Rheumatol,1993

2. Development of a disease activity score based on judgment in clinical practice by rheumatologists;Van der Heijde;J Rheumatol,1993

3. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis;Prevoo;Arthritis Rheum,1995

4. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis;Aletaha;Clin Exp Rheumatol,2005

5. Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations;Pincus;Rheum Dis Clin North Am,2009

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls;Frontiers in Immunology;2024-06-07

2. Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries;Reumatología Clínica;2023-06

3. Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries;Reumatología Clínica (English Edition);2023-06

4. Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis;Frontiers in Immunology;2022-10-12

5. Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials;Rheumatology and Therapy;2022-09-20